Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 22:13:915712.
doi: 10.3389/fneur.2022.915712. eCollection 2022.

Neurological Involvement in COVID-19 Among Non-Hospitalized Adolescents and Young Adults

Lise Beier Havdal  1 , Lise Lund Berven  1 , Joel Selvakumar  1   2 , Tonje Stiansen-Sonerud  1   3 , Truls Michael Leegaard  2   4 , Trygve Tjade  5 , Henrik Zetterberg  6   7   8   9   10 , Kaj Blennow  6   7 , Vegard Bruun Bratholm Wyller  1   2
Affiliations

Neurological Involvement in COVID-19 Among Non-Hospitalized Adolescents and Young Adults

Lise Beier Havdal et al. Front Neurol. .

Abstract

Introduction: Coronavirus disease 2019 (COVID-19) is prevalent among young people, and neurological involvement has been reported. We investigated neurological symptoms, cognitive test results, and biomarkers of brain injury, as well as associations between these variables in non-hospitalized adolescents and young adults with COVID-19.

Methods: This study reports baseline findings from an ongoing observational cohort study of COVID-19 cases and non-COVID controls aged 12-25 years (Clinical Trials ID: NCT04686734). Symptoms were charted using a standardized questionnaire. Cognitive performance was evaluated by applying tests of working memory, verbal learning, delayed recall, and recognition. The brain injury biomarkers, neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAp), were assayed in serum samples using ultrasensitive immunoassays.

Results: A total of 405 COVID-19 cases and 111 non-COVID cases were prospectively included. Serum Nfl and GFAp concentrations were significantly elevated in COVID-19 cases as compared with non-COVID controls (p = 0.050 and p = 0.014, respectively). The COVID-19 cases reported more fatigue (p < 0.001) and post-exertional malaise (PEM) (p = 0.001) compared to non-COVID-19 controls. Cognitive test performance and clinical neurological examination did not differ across the two groups. Within the COVID-19 group, there were no associations between symptoms, cognitive test results, and NfL or GFAp levels. However, fatigue and PEM were strongly associated with older age and female sex.

Conclusions: Non-hospitalized adolescents and young adults with COVID-19 reported more fatigue and PEM and had slightly elevated levels of brain injury markers, but showed normal cognitive performance. No associations were found between symptoms, brain injury markers, and cognitive test results, but fatigue and PEM were strongly related to female sex and older age.

Keywords: COVID-19; Neurofilament (NF); adolescents; cognitive functions; fatigue; glial fibrillary acidic protein (GFAp); post-COVID syndrome.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Flowchart of patient availability, identification, and recruitment process.
Figure 2
Figure 2
Boxplot of brain injury biomarkers according to SARS-CoV-2 status.
See this image and copyright information in PMC

References

    1. Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, et al. . Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. (2020) 382:2268–70. 10.1056/NEJMc2008597 - DOI - PMC - PubMed
    1. Beyrouti R, Adams ME, Benjamin L, Cohen H, Farmer SF, Goh YY, et al. . Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry. (2020) 91:889–91. 10.1136/jnnp-2020-323586 - DOI - PMC - PubMed
    1. Paterson RW, Brown RL, Benjamin L, Nortley R, Wiethoff S, Bharucha T, et al. . The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain. (2020) 143:3104–20. 10.1093/brain/awaa240 - DOI - PMC - PubMed
    1. Varatharaj A, Thomas N, Ellul MA, Davies NWS, Pollak TA, Tenorio EL, et al. . Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry. (2020) 7:875–82. 10.1016/S2215-0366(20)30287-X - DOI - PMC - PubMed
    1. Franke C, Ferse C, Kreye J, Reincke SM, Sanchez-Sendin E, Rocco A, et al. . High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms. Brain Behav Immun. (2021) 93:415–9. 10.1016/j.bbi.2020.12.022 - DOI - PMC - PubMed